BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24858025)

  • 1. Sodium orthovanadate inhibits growth of human hepatocellular carcinoma cells in vitro and in an orthotopic model in vivo.
    Wu Y; Ma Y; Xu Z; Wang D; Zhao B; Pan H; Wang J; Xu D; Zhao X; Pan S; Liu L; Dai W; Jiang H
    Cancer Lett; 2014 Aug; 351(1):108-16. PubMed ID: 24858025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo.
    Xu YZ; Zheng RL; Zhou Y; Peng F; Lin HJ; Bu Q; Mao YQ; Yu LT; Yang L; Yang SY; Zhao YL
    Cancer Lett; 2011 Dec; 313(1):44-53. PubMed ID: 21944661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium orthovanadate inhibits growth of acute leukemia HL60 cells and HL60/A cells in vitro.
    Zhang L; Wei N; Guan G; Song T; Xu Y; Wang S; Zhou J
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32940655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na
    Jiang W; Li G; Li W; Wang P; Xiu P; Jiang X; Liu B; Sun X; Jiang H
    Sci Rep; 2018 Jun; 8(1):9706. PubMed ID: 29946188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of sirolimus on the growth of transplanted hepatocellular carcinoma].
    Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):413-6. PubMed ID: 19567017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells.
    Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q
    Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.
    Zhang DM; Liu JS; Tang MK; Yiu A; Cao HH; Jiang L; Chan JY; Tian HY; Fung KP; Ye WC
    Eur J Pharmacol; 2012 Oct; 692(1-3):19-28. PubMed ID: 22841670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
    Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
    Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
    Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
    Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
    Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y
    Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of hepatocellular carcinoma-specific antitumor activity of the novel thienopyridine derivative TP58.
    Zhou R; Huang WJ; Guo ZY; Li L; Zeng XR; Deng YQ; Hu FY; Tong AP; Yang L; Yang JL
    Oncol Rep; 2012 Jul; 28(1):225-31. PubMed ID: 22552608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
    Qiao F; Zuo D; Shen X; Qi H; Wang H; Zhang W; Wu Y
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):259-70. PubMed ID: 22752214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
    Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Terpineol exhibits potent in vitro and in vivo anticancer effects in Hep-G2 hepatocellular carcinoma cells by suppressing cell migration and inducing apoptosis and sub-G1 cell cycle arrest.
    Liu S; Zhao Y; Cui HF; Cao CY; Zhang YB
    J BUON; 2016; 21(5):1195-1202. PubMed ID: 27837623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide inhibits the early stage of carcinogen-induced hepatocarcinogenesis in mice and suppresses human hepatocellular carcinoma cell growth.
    Park SY; Lee KB; Lee MJ; Bae SC; Jang JJ
    J Cell Physiol; 2012 Mar; 227(3):899-908. PubMed ID: 21503886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.